Back
Day Range
$4.52
$4.75
52-Week Range
$2.37
$6.18
Volume
726,609
50D / 200D Avg
$4.71
/
$4.27
Prev Close
$4.48
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -9.1 | 0.4 |
| P/B | 1.8 | 2.9 |
| ROE % | -18.1 | 3.8 |
| Net Margin % | -33.0 | 3.9 |
| Rev Growth 5Y % | 12.0 | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
Hold
$6.00
+27.4%
Forward EPS
-$0.21
Est. Revenue
210 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2029 |
-$0.08
-$0.08 – -$0.08
|
260 M | 1 |
| FY2028 |
-$0.05
-$0.05 – -$0.05
|
250 M | 2 |
| FY2027 |
-$0.14
-$0.17 – -$0.09
|
220 M | 2 |
Key Takeaways
Revenue grew 12.02% annually over 5 years — strong growth
Debt/Equity of 0.10 — conservative balance sheet
Negative free cash flow of -8.77M
Revenue growth is decelerating — 1Y growth trails 5Y average by 11.50%
Capital efficient — spends only 2.03% of revenue on capex
Growth
Revenue Growth (5Y)
12.02%
Revenue (1Y)0.52%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-18.05%
ROIC-8.08%
Net Margin-33.02%
Op. Margin-20.04%
Safety
Debt / Equity
0.10
Current Ratio5.04
Interest Coverage-85.20
Valuation
P/E Ratio
-9.10
P/B Ratio1.77
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 0.52% | Revenue Growth (3Y) | 2.17% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 12.02% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 201.49M | Net Income (TTM) | -66.54M |
| ROE | -18.05% | ROA | -14.42% |
| Gross Margin | 51.84% | Operating Margin | -20.04% |
| Net Margin | -33.02% | Free Cash Flow (TTM) | -8.77M |
| ROIC | -8.08% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.10 | Current Ratio | 5.04 |
| Interest Coverage | -85.20 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -9.10 | P/B Ratio | 1.77 |
| P/S Ratio | 3.00 | PEG Ratio | -0.01 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 605.47M | Enterprise Value | 547.64M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 201.49M | 200.45M | 193.02M | 164.04M | 127.95M |
| Net Income | -66.54M | -6.02M | -12.15M | 2.58M | 3.00M |
| EPS (Diluted) | -0.52 | -0.05 | -0.09 | 0.02 | 0.03 |
| Gross Profit | 104.46M | 111.11M | 109.43M | 100.97M | 79.14M |
| Operating Income | -40.38M | -20.52M | -27.85M | -1.80M | 9.16M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 461.54M | 499.50M | 494.46M | 519.48M | 463.31M |
| Total Liabilities | 119.80M | 103.76M | 101.39M | 93.93M | 57.92M |
| Shareholders' Equity | 341.74M | 395.74M | 393.06M | 425.30M | 405.04M |
| Total Debt | 33.02M | 17.02M | 14.14M | 18.09M | 0.0 |
| Cash & Equivalents | 90.85M | 98.72M | 167.30M | 296.60M | 364.62M |
| Current Assets | 392.00M | 396.45M | 392.06M | 454.02M | 431.73M |
| Current Liabilities | 77.80M | 67.66M | 56.23M | 49.04M | 33.18M |